PAH treatment: PDE5-in & ET-1A
Authored by Adeline Kamaliza
Science
University
Used 1+ times
AI Actions
Add similar questions
Adjust reading levels
Convert to real-world scenario
Translate activity
More...
Content View
Student View
9 questions
Show all answers
1.
MULTIPLE SELECT QUESTION
45 sec • 1 pt
1st line in positive reactive test
diltiazem
amlodipine
nifedipine
2.
MULTIPLE CHOICE QUESTION
30 sec • 1 pt
1st line in positive reactive test ( pt has tachycardia, so drug is best for negative ionotropic properties)
diltiazem240-720
amlodipine20- 30mg
nifedipine120-240mg
3.
MULTIPLE SELECT QUESTION
45 sec • 1 pt
FDA approved PDE-5in
sildanafil ( LOE A)
tadalafil
avonafil
4.
MULTIPLE SELECT QUESTION
45 sec • 1 pt
sildenafil and tadalafil cannot be given with
( no REMS program)
CCB
RIOCIGAT
nitrates
BBB
5.
MULTIPLE CHOICE QUESTION
30 sec • 1 pt
headache, myalgia, flushing, dyspesia, vision changes are ADEs of
sildanafil
tadalafil
6.
MULTIPLE CHOICE QUESTION
30 sec • 1 pt
epistxis, diarrhea, sudden vision loss are ADEs
sildanafil
tadalafil
7.
MULTIPLE CHOICE QUESTION
30 sec • 1 pt
If Patient is on Bosentan( inducer CYP3A4) we must …........levels of sildenafil and tadafil by 50%
increase
decrease
Access all questions and much more by creating a free account
Create resources
Host any resource
Get auto-graded reports
Continue with Google
Continue with Email
Continue with Classlink
Continue with Clever
or continue with
Microsoft
%20(1).png)
Apple
Others
Already have an account?
